Evidence map›Paper›PMID 29289692›Full record

ReviewBiotechnology advances2018

Activation of Nrf2 signaling by natural products-can it alleviate diabetes?

Manuel Matzinger, Katrin Fischhuber, Elke H Heiss

Open access · hybridAbstract readReview
In one paragraph

Review in Biotechnology advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed, 2 pooled it
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 2 syntheses or guidelines pooled it, 204 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Manuel MatzingerUniversity of Vienna, Department of Pharmacognosy, Althanstrasse 14, 1090 Vienna, Austria.
Katrin FischhuberUniversity of Vienna, Department of Pharmacognosy, Althanstrasse 14, 1090 Vienna, Austria.
Elke H HeissUniversity of Vienna, Department of Pharmacognosy, Althanstrasse 14, 1090 Vienna, Austria. Electronic address: elke.heiss@univie.ac.at.
University of Vienna · AT

Funding

Austrian Science Fund FWF P 29392
6 · The paper itself

Abstract

Type 2 diabetes mellitus (DM) has reached pandemic proportions and effective prevention strategies are wanted. Its onset is accompanied by cellular distress, the nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor boosting cytoprotective responses, and many phytochemicals activate Nrf2 signaling. Thus, Nrf2 activation by natural products could presumably alleviate DM. We summarize function, regulation and exogenous activation of Nrf2, as well as diabetes-linked and Nrf2-susceptible forms of cellular stress. The reported amelioration of insulin resistance, β-cell dysfunction and diabetic complications by activated Nrf2 as well as the status quo of Nrf2 in precision medicine for DM are reviewed.

Indexed as

Diabetes Mellitus, Type 2NF-E2-Related Factor 2Signal TransductionAnimalsBiological ProductsBlood GlucoseHumansHypoglycemic AgentsMiceMice, KnockoutBiological ProductsBlood GlucoseHypoglycemic AgentsNFE2L2 protein, humanNF-E2-Related Factor 2cellular stresshyperglycemiainsulin sensitivitynatural productsNrf2type 2 diabetesvascular complicationsβ-cell function

Identifiers

PMID29289692
PMCPMC5967606
OpenAlexW2776142915

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.